Recently, it was shown that breast cancer patients with elevated DARPP-32 expression but low PP1 expression have worse overall survival than those with low expression of DARPP-3252, suggesting a strong inverse correlation between PP1 and DARPP-32 proteins in patient outcome. This evidence concerns the gene PPP1R1B and breast carcinoma.